AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:AEZS

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/12/14	22 : 18	PR Newswire (Canada)	L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2023/12/14	22 : 16	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trade Resumption - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2023/12/14	22 : 14	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2023/12/14	22 : 12	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2019/03/13	20 : 53	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2019/03/13	20 : 52	PR Newswire (Canada)	IIROC Trade Resumption - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2019/03/13	04 : 32	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2019/03/13	04 : 27	PR Newswire (Canada)	IIROC Trading Halt - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/12/21	22 : 26	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - AEZS; BNE	TSX:AEZS	Aeterna Zentaris Inc
2017/12/21	22 : 23	PR Newswire (Canada)	IIROC Trade Resumption - AEZS; BNE	TSX:AEZS	Aeterna Zentaris Inc
2017/12/21	06 : 24	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/12/21	06 : 23	PR Newswire (Canada)	IIROC Trading Halt - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/08/09	20 : 41	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/08/09	20 : 39	PR Newswire (Canada)	IIROC Trade Resumption - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/08/09	05 : 35	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/08/09	05 : 32	PR Newswire (Canada)	IIROC Trading Halt - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/05/01	21 : 50	PR Newswire (Canada)	IIROC Trade Resumption - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/05/01	21 : 47	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/05/01	21 : 46	PR Newswire (Canada)	IIROC Trade Resumption - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/05/01	21 : 12	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2017/05/01	21 : 10	PR Newswire (Canada)	IIROC Trading Halt - AEZS	TSX:AEZS	Aeterna Zentaris Inc
2010/02/03	22 : 35	PR Newswire (US)	AEterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-040	NASDAQ:AEZS
2010/01/29	22 : 35	PR Newswire (US)	AEterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced	NASDAQ:AEZS
2010/01/29	22 : 30	PR Newswire (US)	Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced	NASDAQ:AEZS
2010/01/28	06 : 00	PR Newswire (US)	Keryx Biopharmaceuticals, Inc. to Conduct Conference Call to Discuss KRX-0401 (Perifosine) Clinical Development Program in Color	NASDAQ:AEZS
2010/01/25	22 : 35	PR Newswire (US)	AEterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Dou	NASDAQ:AEZS
2010/01/25	22 : 30	PR Newswire (US)	Keryx Reports Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controll	NASDAQ:AEZS
2010/01/23	06 : 05	PR Newswire (US)	AEterna Zentaris Receives NASDAQ Notification Related to Minimum Bid Price	NASDAQ:AEZS
2010/01/21	22 : 35	PR Newswire (US)	AEterna Zentaris Partner, Keryx Biopharmaceuticals, to Present Poster Highlighting Clinical Activity of Perifosine (KRX-0401) at	NASDAQ:AEZS
2010/01/21	22 : 30	PR Newswire (US)	Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the ASCO 2010	NASDAQ:AEZS